Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage
Open Access
- 14 February 2022
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 8 (8) , e2100266
Abstract
PURPOSE: The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer.METHODS: A narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia.RESULTS: There is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships.CONCLUSION: There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.Keywords
This publication has 120 references indexed in Scilit:
- Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup studyThe Lancet Oncology, 2012
- Treatment of nephroblastoma in Africa: Results of the first French African pediatric oncology group (GFAOP) studyPediatric Blood & Cancer, 2011
- Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007Cancer, 2010
- Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemiaLeukemia, 2009
- Cisplatin and Etoposide in Childhood Germ Cell Tumor: Brazilian Pediatric Oncology Society Protocol GCT-91Journal of Clinical Oncology, 2009
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology GroupSeminars in Oncology, 2008
- Team management, twinning, and telemedicine in retinoblastoma: A 3‐tier approach implemented in the first eye salvage program in JordanPediatric Blood & Cancer, 2008
- Transfer of complex frontline anticancer therapy to a developing country: The St. Jude osteosarcoma experience in ChilePediatric Blood & Cancer, 2007
- Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 resultsLeukemia, 2005
- Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: Experience of the Brazilian Wilms' tumor study groupMedical and Pediatric Oncology, 1994